Interleukin-1 receptor antagonist: a "novel" acute phase protein with antiinflammatory activities.

Por Cominelli, F, Pizarro, T T
Publicado em 1997

Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease

Por Arseneau, KO, Cominelli, F
Publicado no Clin Pharmacol Ther (2014)

Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?

Por Pizarro, T T, De La Rue, S A, Cominelli, F
Publicado em 2006

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.

Por Ferretti, M, Casini-Raggi, V, Pizarro, T T, Eisenberg, S P, Nast, C C, Cominelli, F
Publicado em 1994

Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins.

Por Cominelli, F, Nast, C C, Llerena, R, Dinarello, C A, Zipser, R D
Publicado em 1990

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

Por Cominelli, F, Nast, C C, Clark, B D, Schindler, R, Lierena, R, Eysselein, V E, Thompson, R C, Dinarello, C A
Publicado em 1990

Genetic Deletion of the Bacterial Sensor NOD2 Improves Murine Crohn’s Disease-like Ileitis Independent of Functional Dysbiosis

Por Corridoni, D., Palacios, A. Rodriguez, Di Stefano, G., Di Martino, L., Antonopoulos, D.A., Chang, E.B., Arseneau, K.O., Pizarro, T.T., Cominelli, F.
Publicado no Mucosal Immunol (2016)